WallStreetZenWallStreetZen

NASDAQ: ROIV
Roivant Sciences Ltd Stock Ownership - Who owns Roivant Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Roivant Sciences Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eric VenkerPresident Immunovant CEO2026-04-20200,000$29.59
$5.92MSell
Eric VenkerPresident Immunovant CEO2026-04-20200,000$3.85
$770.00kBuy
Ilan OrenDirector2026-04-1795$29.83
$2.83kSell
James C. MomtazeeDirector2026-04-1794$29.83
$2.80kSell
Matthew GlineCEO2026-04-16289,774$29.16
$8.45MSell
Jennifer HumesChief Accounting Officer2026-04-0813,538$28.37
$384.07kSell
Matthew GlineCEO2026-03-31304,684$27.70
$8.44MSell
Frank TortiPresident and Vant Chair2026-03-31160,035$27.70
$4.43MSell
Mayukh SukhatmePresident CIO2026-03-31187,512$27.70
$5.19MSell
Mayukh SukhatmePresident CIO2026-03-3029,809$26.41
$787.26kSell

1 of 20

ROIV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ROIV insiders and whales buy or sell their stock.

ROIV Shareholders

What type of owners hold Roivant Sciences Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Qvt Financial LP16.11%115,268,226$3.24BInsider
Daniel Allen Gold15.14%108,333,636$3.05BInsider
Dexcel Pharma Technologies Ltd14.37%102,849,443$2.89BInsider
Keith S. Manchester10.22%73,167,574$2.06BInsider
Svf Investments Uk Ltd10.20%73,031,667$2.06BInsider
Sumitomo Chemical Co Ltd9.96%71,251,083$2.01BInsider
Fmr LLC9.19%65,779,464$1.85BInstitution
Morgan Stanley8.15%58,359,553$1.64BInstitution
Vivek Ramaswamy6.57%47,011,612$1.32BInsider
Vanguard Group Inc5.88%42,059,041$1.18BInstitution

1 of 3

ROIV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ROIV43.13%56.87%Net SellingNet Selling
MRNA77.07%22.51%Net BuyingNet Selling
INCY77.92%22.08%Net SellingNet Selling
GMAB100.00%0.00%
SMMT8.32%91.68%Net Buying
View Top Biotech Stocks

Roivant Sciences Stock Ownership FAQ

Who owns Roivant Sciences?

Roivant Sciences (NASDAQ: ROIV) is owned by 71.11% institutional shareholders, 93.76% Roivant Sciences insiders, and 0.00% retail investors. Qvt Financial LP is the largest individual Roivant Sciences shareholder, owning 115.27M shares representing 16.11% of the company. Qvt Financial LP's Roivant Sciences shares are currently valued at $3.16B.

If you're new to stock investing, here's how to buy Roivant Sciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.